DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
SUN PHARM · DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Open FDA's page for this record- Application number
- ANDA211491
- Sponsor name
- SUN PHARM
- Submissions
- Submission type
- ORIG
- Submission number
- 2
- Submission status
- TA
- Submission status date
- 20260406
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260406
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Application docs
- ID
- 60240
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211491Orig1s000_TAltr.pdf
- Date
- 20191004
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260521
- Review priority
- UNKNOWN
- Submission class code
- MANUF (CMC)
- Submission class code description
- Manufacturing (CMC)
- Products
- Product number
- 002
- Reference drug
- No
- Brand name
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DAPAGLIFLOZIN
- Strength
- 10MG
- Name
- METFORMIN HYDROCHLORIDE
- Strength
- 500MG
- Product number
- 003
- Reference drug
- No
- Brand name
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DAPAGLIFLOZIN
- Strength
- 10MG
- Name
- METFORMIN HYDROCHLORIDE
- Strength
- 1GM
- Product number
- 001
- Reference drug
- No
- Brand name
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DAPAGLIFLOZIN
- Strength
- 5MG
- Name
- METFORMIN HYDROCHLORIDE
- Strength
- 1GM
